{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:13:17Z","timestamp":1750219997755,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":83,"publisher":"ACM","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,29]]},"DOI":"10.1145\/3500931.3500988","type":"proceedings-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T05:13:49Z","timestamp":1640236429000},"page":"322-329","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["On the Treatment of MRSA Skin and Soft Tissue Infection with Ceftaroline and Linezolid"],"prefix":"10.1145","author":[{"given":"Kaiwen","family":"Chen","sequence":"first","affiliation":[{"name":"Division of Engineering Science, University of Toronto, Toronto, Canada"}]}],"member":"320","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"volume-title":"Skin and Soft Tissue Infections,\" Microbiol Spectr","author":"Moffarah A. S.","key":"e_1_3_2_1_1_1","unstructured":"A. S. Moffarah , M. A. Mohajer , B. L. Hurwitz and D. G. Armstrong , \" Skin and Soft Tissue Infections,\" Microbiol Spectr , vol. 4 , no. 4, 2016. A. S. Moffarah, M. A. Mohajer, B. L. Hurwitz and D. G. Armstrong, \"Skin and Soft Tissue Infections,\" Microbiol Spectr, vol. 4, no. 4, 2016."},{"key":"e_1_3_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/846453"},{"issue":"362","key":"e_1_3_2_1_3_1","first-page":"1","article-title":"Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010","volume":"15","author":"Miller L. G.","year":"2015","unstructured":"L. G. Miller , D. F. Eisenberg , H. Liu , C.-L. Chang , Y. Wang , R. Luthra , A. Wallace , C. Fang , J. Singer and J. A. Suaya , \" Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010 ,\" BMC Infect Dis. , vol. 15 , no. 362 , pp. 1 -- 8 , 2015 . L. G. Miller, D. F. Eisenberg, H. Liu, C.-L. Chang, Y. Wang, R. Luthra, A. Wallace, C. Fang, J. Singer and J. A. Suaya, \"Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010,\" BMC Infect Dis., vol. 15, no. 362, pp. 1--8, 2015.","journal-title":"BMC Infect Dis."},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(02)00543-6"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03221-14"},{"issue":"5219","key":"e_1_3_2_1_6_1","first-page":"124","volume":"1","author":"Jevons P.","year":"1961","unstructured":"P. Jevons , \"\" Celbenin\" - resistant Staphylococci,\" British Medical Journal , vol. 1 , no. 5219 , pp. 124 -- 125 , 1961 . P. Jevons, \"\"Celbenin\" - resistant Staphylococci,\" British Medical Journal, vol. 1, no. 5219, pp. 124--125, 1961.","journal-title":"Celbenin\" - resistant Staphylococci,\" British Medical Journal"},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1086\/367653"},{"issue":"3900","key":"e_1_3_2_1_8_1","first-page":"1","article-title":"Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China","volume":"10","author":"Zhen X.","year":"2020","unstructured":"X. Zhen , C. S. Lundborg , M. Zhang , X. Su'n , Y. Li , X. Hu , S. Gu , Y. Gu , J. Wei and H. Dong , \" Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China ,\" Scientific Reports , vol. 10 , no. 3900 , pp. 1 -- 8 , 2020 . X. Zhen, C. S. Lundborg, M. Zhang, X. Su'n, Y. Li, X. Hu, S. Gu, Y. Gu, J. Wei and H. Dong, \"Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China,\" Scientific Reports, vol. 10, no. 3900, pp. 1--8, 2020.","journal-title":"Scientific Reports"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6809e1"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223599"},{"key":"e_1_3_2_1_11_1","unstructured":"Centers for Disease Control and Prevention \"Antibiotic Resistance Threats in the United States 2019 \" pp. 0--150 2019.  Centers for Disease Control and Prevention \"Antibiotic Resistance Threats in the United States 2019 \" pp. 0--150 2019."},{"first-page":"0","volume-title":"2021","key":"e_1_3_2_1_12_1","unstructured":"WHO, \"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report : 2021 ,\" pp. 0 -- 168 . WHO, \"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021,\" pp. 0--168."},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70295-4"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-664-1_8"},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir845"},{"issue":"5","key":"e_1_3_2_1_16_1","first-page":"6","article-title":"Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization","volume":"298","author":"Weidenmaier C.","year":"2008","unstructured":"C. Weidenmaier , J. F. Kokai-Kun , E. Kulauzovic , T. Kohler , G. Thumm , H. Stoll , F. G\u00f6tz and A. Peschel , \" Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization ,\" International Journal of Medical Microbiology , vol. 298 , no. 5 -- 6 , pp. 505--513, 2008 . C. Weidenmaier, J. F. Kokai-Kun, E. Kulauzovic, T. Kohler, G. Thumm, H. Stoll, F. G\u00f6tz and A. Peschel, \"Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization,\" International Journal of Medical Microbiology, vol. 298, no. 5--6, pp. 505--513, 2008.","journal-title":"International Journal of Medical Microbiology"},{"issue":"5","key":"e_1_3_2_1_17_1","first-page":"S351","article-title":"Pathogenesis of Methicillin-Resistant Staphylococcus aureus Infection","volume":"46","author":"Gordon R. J.","year":"2008","unstructured":"R. J. Gordon and F. D. Lowy , \" Pathogenesis of Methicillin-Resistant Staphylococcus aureus Infection ,\" Clinical Infectious Diseases , vol. 46 , no. 5 , pp. S351 - S359 , 2008 . R. J. Gordon and F. D. Lowy, \"Pathogenesis of Methicillin-Resistant Staphylococcus aureus Infection,\" Clinical Infectious Diseases, vol. 46, no. 5, pp. S351-S359, 2008.","journal-title":"Clinical Infectious Diseases"},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2011.01.007"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1137165"},{"key":"e_1_3_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1207-1405"},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002271"},{"key":"e_1_3_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-017-0001-x"},{"key":"e_1_3_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.15.1763"},{"key":"e_1_3_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055356"},{"issue":"6","key":"e_1_3_2_1_25_1","first-page":"7","article-title":"Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany","volume":"303","author":"Cuny C.","year":"2013","unstructured":"C. Cuny , R. K\u00f6ck and W. Witte , \" Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany ,\" International Journal of Medical Microbiology , vol. 303 , no. 6 -- 7 , pp. 331--337, 2013 . C. Cuny, R. K\u00f6ck and W. Witte, \"Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany,\" International Journal of Medical Microbiology, vol. 303, no. 6--7, pp. 331--337, 2013.","journal-title":"International Journal of Medical Microbiology"},{"issue":"18033","key":"e_1_3_2_1_26_1","first-page":"0","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee A. S.","year":"2018","unstructured":"A. S. Lee , H. d. Lencastre , J. Garau , J. Kluytmans , S. Malhotra-Kumar , A. Peschel and S. Harbarth , \" Methicillin-resistant Staphylococcus aureus ,\" Nature Reviews Disease Primers , vol. 4 , no. 18033 , pp. 0 -- 23 , 2018 . A. S. Lee, H. d. Lencastre, J. Garau, J. Kluytmans, S. Malhotra-Kumar, A. Peschel and S. Harbarth, \"Methicillin-resistant Staphylococcus aureus,\" Nature Reviews Disease Primers, vol. 4, no. 18033, pp. 0--23, 2018.","journal-title":"Nature Reviews Disease Primers"},{"key":"e_1_3_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00149-1"},{"key":"e_1_3_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2016.48.4.267"},{"issue":"1854","key":"e_1_3_2_1_29_1","first-page":"0","article-title":"Antibacterial apple cider vinegar eradicates methicillin resistant Staphylococcus aureus and resistant Escherichia coli","volume":"11","author":"Yagnik D.","year":"2021","unstructured":"D. Yagnik , M. Ward and A. J. Shah , \" Antibacterial apple cider vinegar eradicates methicillin resistant Staphylococcus aureus and resistant Escherichia coli ,\" Scientific Reports , vol. 11 , no. 1854 , pp. 0 -- 7 , 2021 . D. Yagnik, M. Ward and A. J. Shah, \"Antibacterial apple cider vinegar eradicates methicillin resistant Staphylococcus aureus and resistant Escherichia coli,\" Scientific Reports, vol. 11, no. 1854, pp. 0--7, 2021.","journal-title":"Scientific Reports"},{"key":"e_1_3_2_1_30_1","first-page":"a2466","article-title":"Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)","volume":"3","author":"Duplessis C.","year":"2012","unstructured":"C. Duplessis and N. F. Crum-Cianflone , \" Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) ,\" Clin Med Rev Ther. , vol. 3 , p. a2466 , 2012 . C. Duplessis and N. F. Crum-Cianflone, \"Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA),\" Clin Med Rev Ther., vol. 3, p. a2466, 2012.","journal-title":"Clin Med Rev Ther."},{"key":"e_1_3_2_1_31_1","volume-title":"StatPearls [Internet]","author":"Bui T.","year":"2021","unstructured":"T. Bui and C. V. Preuss , StatPearls [Internet] , StatPearls Publishing , 2021 . T. Bui and C. V. Preuss, StatPearls [Internet], StatPearls Publishing, 2021."},{"issue":"112829","key":"e_1_3_2_1_32_1","first-page":"1","article-title":"\u03b2-lactam antibiotics: An overview from a medicinal chemistry perspective","volume":"208","author":"Lima L. M.","year":"2020","unstructured":"L. M. Lima , B. N. M. d. Silva , G. Barbosa and E. J. Barreiro , \" \u03b2-lactam antibiotics: An overview from a medicinal chemistry perspective ,\" Eur J Med Chem. , vol. 208 , no. 112829 , pp. 1 -- 25 , 2020 . L. M. Lima, B. N. M. d. Silva, G. Barbosa and E. J. Barreiro, \"\u03b2-lactam antibiotics: An overview from a medicinal chemistry perspective,\" Eur J Med Chem., vol. 208, no. 112829, pp. 1--25, 2020.","journal-title":"Eur J Med Chem."},{"key":"e_1_3_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.63.1.174-229.1999"},{"key":"e_1_3_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2007.06.007"},{"key":"e_1_3_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2008.00104.x"},{"key":"e_1_3_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2007.00089.x"},{"key":"e_1_3_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb700182u"},{"key":"e_1_3_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2008.00105.x"},{"key":"e_1_3_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2007.00094.x"},{"issue":"11","key":"e_1_3_2_1_40_1","first-page":"870","article-title":"Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus","volume":"9","author":"Lim D.","year":"2002","unstructured":"D. Lim and N. C. Strynadka , \" Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus ,\" Nat Struct Biol , vol. 9 , no. 11 , pp. 870 -- 876 , 2002 . D. Lim and N. C. Strynadka, \"Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus,\" Nat Struct Biol, vol. 9, no. 11, pp. 870--876, 2002.","journal-title":"Nat Struct Biol"},{"key":"e_1_3_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja0434376"},{"key":"e_1_3_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300118110"},{"issue":"4","key":"e_1_3_2_1_43_1","first-page":"v17","article-title":"Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study","volume":"65","author":"Jones R. N.","year":"2010","unstructured":"R. N. Jones and H. S. Sader , \" Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study ,\" J Antimicrob Chemother , vol. 65 , no. 4 , pp. i v17 -- v31 , 2010 . R. N. Jones and H. S. Sader, \"Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study,\" J Antimicrob Chemother, vol. 65, no. 4, pp. iv17--31, 2010.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"e_1_3_2_1_44_1","first-page":"v41","article-title":"CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections","volume":"65","author":"Corey R. G.","year":"2010","unstructured":"R. G. Corey , M. H. Wilcox , G. H. Talbot , D. Thye , D. Friedland and T. Baculik , \" CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections ,\" J Antimicrob Chemother , vol. 65 , no. 4 , pp. i v41 -- v51 , 2010 . R. G. Corey, M. H. Wilcox, G. H. Talbot, D. Thye, D. Friedland and T. Baculik, \"CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections,\" J Antimicrob Chemother, vol. 65, no. 4, pp. iv41--51, 2010.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"e_1_3_2_1_45_1","first-page":"v53","article-title":"CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections","volume":"65","author":"Wilcox M. H.","year":"2010","unstructured":"M. H. Wilcox , R. G. Corey , G. H. Talbot , D. Thye , D. Friedland and T. Baculik , \" CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections ,\" J Antimicrob Chemother , vol. 65 , no. 4 , pp. i v53 -- v65 , 2010 . M. H. Wilcox, R. G. Corey, G. H. Talbot, D. Thye, D. Friedland and T. Baculik, \"CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections,\" J Antimicrob Chemother, vol. 65, no. 4, pp. iv53--65, 2010.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1086\/655827"},{"key":"e_1_3_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks069"},{"key":"e_1_3_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.05.061"},{"key":"e_1_3_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2019.03.007"},{"key":"e_1_3_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S75412"},{"key":"e_1_3_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7350.1345"},{"key":"e_1_3_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01471-15"},{"key":"e_1_3_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90915-7"},{"key":"e_1_3_2_1_54_1","first-page":"128","article-title":"5-HALOMETHYL-3-PHENYL-2-OXAZOLIDINONES","volume":"4","author":"Fugitt R. B.","year":"1978","unstructured":"R. B. Fugitt and R. W. Luckenbaugh , \" 5-HALOMETHYL-3-PHENYL-2-OXAZOLIDINONES ,\" United States Patent , Vols. 4 , 128 , 654, 1978 . R. B. Fugitt and R. W. Luckenbaugh, \"5-HALOMETHYL-3-PHENYL-2-OXAZOLIDINONES,\" United States Patent, Vols. 4, 128, 654, 1978.","journal-title":"United States Patent"},{"key":"e_1_3_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.11.1791"},{"key":"e_1_3_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200200528"},{"key":"e_1_3_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm800379d"},{"issue":"2","key":"e_1_3_2_1_58_1","first-page":"i9","article-title":"Linezolid in vitro: mechanism and antibacterial spectrum","volume":"51","author":"Livermore D. M.","unstructured":"D. M. Livermore , \" Linezolid in vitro: mechanism and antibacterial spectrum ,\" J Antimicrob Chemother , vol. 51 , no. 2 , pp. i i9 -ii16, 2003. D. M. Livermore, \"Linezolid in vitro: mechanism and antibacterial spectrum,\" J Antimicrob Chemother, vol. 51, no. 2, pp. ii9-ii16, 2003.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0423-2"},{"key":"e_1_3_2_1_60_1","volume-title":"Linezolid,\" StatPearls[Internet]","author":"Azzouz A.","year":"2021","unstructured":"A. Azzouz and C. V. Preuss , \" Linezolid,\" StatPearls[Internet] , 2021 . A. Azzouz and C. V. Preuss, \"Linezolid,\" StatPearls[Internet], 2021."},{"key":"e_1_3_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg248"},{"key":"e_1_3_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1843-1846.2001"},{"key":"e_1_3_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2367-2371.2005"},{"key":"e_1_3_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.3.720"},{"key":"e_1_3_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg104"},{"volume-title":"Structural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome,\" mBio","author":"Belousoff M. J.","key":"e_1_3_2_1_66_1","unstructured":"M. J. Belousoff , Z. Eyal , M. Radjainia , T. Ahmed , R. S. Bamert , D. Matzov , A. Bashan , E. Zimmerman , S. Mishra , D. Cameron , H. Elmlund , A. Y. Peleg , S. Bhushan , T. Lithgow and A. Yonath , \" Structural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome,\" mBio , vol. 8 , no. 3, pp. e00395--17, 2017. M. J. Belousoff, Z. Eyal, M. Radjainia, T. Ahmed, R. S. Bamert, D. Matzov, A. Bashan, E. Zimmerman, S. Mishra, D. Cameron, H. Elmlund, A. Y. Peleg, S. Bhushan, T. Lithgow and A. Yonath, \"Structural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome,\" mBio, vol. 8, no. 3, pp. e00395--17, 2017."},{"key":"e_1_3_2_1_67_1","volume-title":"York","author":"Bounthavong M.","year":"2010","unstructured":"M. Bounthavong and D. Hsu , Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis , York , 2010 . M. Bounthavong and D. Hsu, Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis, York, 2010."},{"key":"e_1_3_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2009.05018.x"},{"key":"e_1_3_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2011.062"},{"key":"e_1_3_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70312-2"},{"issue":"8","key":"e_1_3_2_1_71_1","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.clinthera.2012.06.018","article-title":"Helen Bhattacharyya and A. M. Baruch, \"Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis","volume":"34","author":"Itani K. M. F.","year":"2012","unstructured":"K. M. F. Itani , P. Biswas , A. Reisman , H . Helen Bhattacharyya and A. M. Baruch, \"Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis ,\" Clin Ther , vol. 34 , no. 8 , pp. 1667 -- 1673 , 2012 . K. M. F. Itani, P. Biswas, A. Reisman, H. Helen Bhattacharyya and A. M. Baruch, \"Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis,\" Clin Ther, vol. 34, no. 8, pp. 1667--1673, 2012.","journal-title":"Clin Ther"},{"key":"e_1_3_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1086\/497271"},{"key":"e_1_3_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.12.3408-3413.2000"},{"key":"e_1_3_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2260-2266.2005"},{"key":"e_1_3_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh088"},{"issue":"1","key":"e_1_3_2_1_76_1","first-page":"D008056","article-title":"Linezolid versus vancomycin for skin and soft tissue infections","volume":"7","author":"Yue J.","unstructured":"J. Yue , B. R. Dong , M. Yang , X. Chen , T. Wu and G. J. Liu , \" Linezolid versus vancomycin for skin and soft tissue infections ,\" Cochrane Database Syst Rev. , vol. 7 , no. 1 , p. C D008056 ., 2016. J. Yue, B. R. Dong, M. Yang, X. Chen, T. Wu and G. J. Liu, \"Linezolid versus vancomycin for skin and soft tissue infections,\" Cochrane Database Syst Rev., vol. 7, no. 1, p. CD008056., 2016.","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"e_1_3_2_1_77_1","first-page":"379","article-title":"A critical review of oxazolidinones: An alternative or replacement for glycopeptides and streptogramins?","volume":"12","author":"Zhanel G. G.","year":"2001","unstructured":"G. G. Zhanel , C. Shroeder , L. Vercaigne , A. S. Gin , J. Embil and D. J. Hoban , \" A critical review of oxazolidinones: An alternative or replacement for glycopeptides and streptogramins? \" Can J Infect Dis , vol. 12 , no. 6 , pp. 379 -- 390 , 2001 . G. G. Zhanel, C. Shroeder, L. Vercaigne, A. S. Gin, J. Embil and D. J. Hoban, \"A critical review of oxazolidinones: An alternative or replacement for glycopeptides and streptogramins?\" Can J Infect Dis, vol. 12, no. 6, pp. 379--390, 2001.","journal-title":"Can J Infect Dis"},{"key":"e_1_3_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(09)60009-8"},{"issue":"7","key":"e_1_3_2_1_79_1","first-page":"893","article-title":"Skin and soft tissue infections in immunocompetent patients","volume":"81","author":"Breen J. O.","year":"2010","unstructured":"J. O. Breen , \" Skin and soft tissue infections in immunocompetent patients ,\" Am Fam Physician , vol. 81 , no. 7 , pp. 893 -- 899 , 2010 . J. O. Breen, \"Skin and soft tissue infections in immunocompetent patients,\" Am Fam Physician, vol. 81, no. 7, pp. 893--899, 2010.","journal-title":"Am Fam Physician"},{"issue":"4","key":"e_1_3_2_1_80_1","first-page":"247","article-title":"Comparative Efficacy of Ceftaroline with Linezolid against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus","volume":"25","author":"Hafeez A.","year":"2015","unstructured":"A. Hafeez , T. Munir , S. Rehman , S. Najeeb , M. Gilani , M. Latif , M. Ansari and N. Saad , \" Comparative Efficacy of Ceftaroline with Linezolid against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus ,\" J Coll Physicians Surg Pak , vol. 25 , no. 4 , pp. 247 -- 249 , 2015 . A. Hafeez, T. Munir, S. Rehman, S. Najeeb, M. Gilani, M. Latif, M. Ansari and N. Saad, \"Comparative Efficacy of Ceftaroline with Linezolid against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus,\" J Coll Physicians Surg Pak, vol. 25, no. 4, pp. 247--249, 2015.","journal-title":"J Coll Physicians Surg Pak"},{"key":"e_1_3_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/585603"},{"key":"e_1_3_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp120438"},{"key":"e_1_3_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2015-0024"}],"event":{"name":"ISAIMS 2021: 2nd International Symposium on Artificial Intelligence for Medicine Sciences","acronym":"ISAIMS 2021","location":"Beijing China"},"container-title":["Proceedings of the 2nd International Symposium on Artificial Intelligence for Medicine Sciences"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3500931.3500988","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3500931.3500988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:50:52Z","timestamp":1750182652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3500931.3500988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":83,"alternative-id":["10.1145\/3500931.3500988","10.1145\/3500931"],"URL":"https:\/\/doi.org\/10.1145\/3500931.3500988","relation":{},"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"2021-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}